Form EFFECT AGOMAB THERAPEUTICS NV/A
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 30, 2026 4:01 P.M. |
| Form: | F-6 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LVMH: Continued growth in the third quarter of 2026
- Eylsia Nicolas Announces Medical Hiatus From Live Singing, Launches HHGC Studios, and Introduces New Transparency Standards for AI‑Integrated Creative Work
- Indoor Play Center Design for Comfort and Development Explained by Children's Play Expert Kristen Bonn in HelloNation
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share